Volume 52, Issue 5, Pages (November 2007)

Slides:

Advertisements

Similar presentations

Pascal Rischmann European Urology Supplements

Advertisements

The PSA Era is not Over for Prostate Cancer

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 44, Issue 6, Pages (December 2003)

Reversible, Non-Barrier Male Contraception: Status and Prospects

Testosterone Therapy in Men With Prostate Cancer

Volume 63, Issue 5, Pages (May 2013)

Global Trends in Testicular Cancer Incidence and Mortality

Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer Marisa Warmuth,

Volume 69, Issue 2, Pages (February 2016)

Volume 72, Issue 5, Pages (November 2017)

Association between Smoking, Passive Smoking, and Erectile Dysfunction: Results from the Boston Area Community Health (BACH) Survey Varant Kupelian,

Volume 64, Issue 4, Pages (October 2013)

Control of Prostate Cancer by Transrectal HIFU in 227 Patients

Volume 50, Issue 5, Pages (November 2006)

Volume 69, Issue 1, Pages (January 2016)

Volume 60, Issue 1, Pages (July 2011)

Volume 66, Issue 6, Pages (December 2014)

Volume 70, Issue 2, Pages (August 2016)

Let the Games Begin (with EAU Approval)

Prostate Cancer Epidemic in Sight?

Can Low-Intensity Extracorporeal Shockwave Therapy Improve Erectile Function? A 6- Month Follow-up Pilot Study in Patients with Organic Erectile Dysfunction

John P. Mulhall, Francesco Montorsi European Urology

Toxicities of Targeted Therapy and Their Management in Kidney Cancer

The Global Risk of Bladder Cancer: Let's Just Do Something About It!

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Irritability in a mixed sample of patients with unipolar and bipolar II depression predicts responsiveness to lamotrigine Evyn M. Peters, Rudy Bowen

Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey John B. McKinlay, Carol L. Link European.

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Prostate Cancer Detection: A View of the Future

Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance Adam B. Weiner, Ruth Etzioni, Scott E. Eggener

P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes European Urology

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 64, Issue 4, Pages (October 2013)

Volume 64, Issue 3, Pages (September 2013)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Counselling the Prostate Cancer Patient

Volume 65, Issue 3, Pages (March 2014)

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 53, Issue 6, Pages (June 2008)

Volume 62, Issue 4, Pages (October 2012)

Trends in Hypospadias Surgery: Results of a Worldwide Survey

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

The Economic Costs of Overactive Bladder in Germany

Volume 70, Issue 2, Pages (August 2016)

Volume 50, Issue 5, Pages (November 2006)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 55, Issue 3, Pages (March 2009)

Volume 74, Issue 5, Pages (November 2018)

Testicular Cancer Variations in Time and Space in Europe

Volume 53, Issue 1, Pages (January 2008)

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Volume 72, Issue 5, Pages (November 2017)

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

Christian Stief European Urology Supplements

European Urology is “Your” Journal

Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders

The Start-Up of the Platinum Journal: A Fascinating Challenge

A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study John Fitzpatrick European.

Economic Burden of Bladder Cancer Across the European Union

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Volume 53, Issue 2, Pages (February 2008)

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Diagnosis and Management of Cryptorchidism

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 52, Issue 5, Pages 1448-1455 (November 2007) The Quality of Life and Hormonal Disturbances in Testicular Cancer Survivors in Cisplatin Era Paweł Wiechno, Tomasz Demkow, Krzysztof Kubiak, Małgorzata Sadowska, Janina Kamińska European Urology Volume 52, Issue 5, Pages 1448-1455 (November 2007) DOI: 10.1016/j.eururo.2007.05.012 Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 1 Hormonal abnormalities among testicular cancer patients. LH=luteinizing hormone; FSH=follicle-stimulating hormone; PRL=prolactin; TSH=thyroid-stimulating hormone. European Urology 2007 52, 1448-1455DOI: (10.1016/j.eururo.2007.05.012) Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 2 Mean ranks of hormone levels in testicular cancer patients and the intensity of chemotherapy. LH=luteinizing hormone; FSH=follicle-stimulating hormone. European Urology 2007 52, 1448-1455DOI: (10.1016/j.eururo.2007.05.012) Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 3 The percentage of testicular cancer patients with abnormal scores in response to standardized questionnaires. STAI=State Trait Anxiety Inventory; HADS=Hospital Anxiety and Depression Scale; BDI=the Beck’s Depression Inventory; IIEF=the International Index of Erectile Function. European Urology 2007 52, 1448-1455DOI: (10.1016/j.eururo.2007.05.012) Copyright © 2007 European Association of Urology Terms and Conditions